Skip to content

Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries

Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05245721
Enrollment
80
Registered
2022-02-18
Start date
2022-03-31
Completion date
2023-02-28
Last updated
2022-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation, Emergence, Post Operative Pain

Brief summary

Effect of caudal nalbuphine on postoperative emergence agitation in pediatrics undergoing infra-umbilical surgeries and pain assessment

Interventions

DRUGNalbuphine

Caudal nalbuphine injection in pediatrics undergoing infra-umbilical surgeries

DRUGBupivacain

Caudal bupivacaine in pediatrics undergoing infra-umbilical surgeries

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
2 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 2\_12 years * Both genders * ASA I\_II * Children undergoing infra-umbilical surgeries

Exclusion criteria

* Guardians refusal * congenital anomalies at the lower spine or meringues * Increased intracranial pressure * Skin infection at site of injection * Bleeding diathesis * Known allergy to any drugs used

Design outcomes

Primary

MeasureTime frameDescription
Effect of caudal nalbuphine on postoperative emergence agitation according to Pediatric Anasthesia emergence delirium (PAED)Up to 2 hours postoperativePAED ( The pediatric anesthesia emergence delirium scale)

Secondary

MeasureTime frame
Postoperative pain assessment according to Modified Children's Hospital of Eastern Ontario Pain Scale (modified CHEOPS)For 24 hours postoperative

Contacts

Primary ContactRehab Adel Ebrahim
Adelrehab273@gmail.com01099070718
Backup ContactMohamed Fathy Mostafa, Assistant professor
mo7_fathy@yahoo.com01001123062

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026